VAV3 and prostate carcinoma: Lyons et al. reported that Vav3 expression is elevated in prostate cancer specimens and is coupled to growth factor receptor pathways that are upregulated during the progression of androgen-dependent prostate cancer cells to the androgen-independent state [15].